PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10948492
APP PUB NO 20180238884A1
SERIAL NO

15553225

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is based on the identification of novel biomarkers predictive of responsiveness of esophagogastric cancers to inhibitors of the PD-1 pathway.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DANA-FARBER CANCER INSTITUTE INC44 BINNEY STREET BOSTON MA 02115

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bass, Adam Somerville, US 3 7
Derks, Sarah Boston, US 1 6
Freeman, Gordon J Brookline, US 88 2549
Rodig, Scott J Westwood, US 12 112

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 16, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 16, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00